| Literature DB >> 30805450 |
Mohammed ElSayed Hashim1, Reem Nabil Said1, Enas Abdallah Ali Abdallah1, Heba F Abd Elghafar2.
Abstract
BACKGROUND AND OBJECTIVES: Neonatal jaundice is one of the most prevalent clinical conditions requiring evaluation and management within the first few days of life. Phototherapy is the single most common intervention used for the treatment of neonatal jaundice. The aim of our study was to evaluate the efficacy and tolerability of phototherapy with reflectors compared to conventional phototherapy in controlling neonatal hyperbilirubinaemia. PATIENTS AND METHODS: In this randomized controlled study, we studied neonates for one year (from June 2010 to June 2011) who were full term and healthy with uncomplicated jaundice and who were admitted to the neonatal intensive care unit (NICU) of El-Nasr General Hospital, Port-Said, Egypt. The subjects were randomized in two groups: group A (n = 30) received phototherapy with reflectors and group B (n = 30) received conventional phototherapy. Serum bilirubin levels were measured on admission and every 12 h thereafter. With declining readings, bilirubin was measured once daily until hospital discharge.Entities:
Keywords: Hyperbilirubinemia; Neonate; Phototherapy
Year: 2015 PMID: 30805450 PMCID: PMC6372435 DOI: 10.1016/j.ijpam.2015.09.003
Source DB: PubMed Journal: Int J Pediatr Adolesc Med ISSN: 2352-6467
Figure 1Phototherapy with reflectors.
Figure 2Study flow chart.
Demographic data and variables at the start of phototherapy.
| Group A (phototherapy with reflectors) (n = 30) | Group B (phototherapy without reflectors) (n = 30) | Total | Significance | ||
|---|---|---|---|---|---|
| Gender | Males | 15 (50.0%) | 13 (43.3%) | 28 (46.7%) | |
| Females | 15 (50.0%) | 17 (56.7%) | 32 (53.3%) | ||
| Mode of delivery | Normal vaginal delivery | 13 (43.3%) | 14 (46.7%) | 27 (45.0%) | |
| Cesarean section | 17 (56.7%) | 16 (53.3%) | 33 (55.0%) | ||
| Weight | 2.93 (0.42) | 3.09 (0.35) | 3.01 (0.39) | ||
| Age | 3.46 (0.89) | 3.83 (1.28) | 3.65 (1.11) | ||
| TSB on admission | 17.88 (2.99) | 16.89 (2.71) | 17.38 (2.87) | ||
| Haemoglobin concentration | 14.76 (1.57) | 14.44 (1.79) | 14.60 (1.68) | ||
| WBCs count | 9.98 (1.29) | 9.12 (1.80) | 9.55 (1.61) | ||
| Platelet count | 325.60 (58.92) | 331.03 (61.13) | 328.32 (59.59) | ||
| Reticulocyte percentage | 1.15 (0.44) | 1.52 (0.52) | 1.33 (0.52) | ||
| Group A | 7 (23.3%) | 5 (16.7%) | 12 (20.0%) | Chi2 = 1.22#, | |
| Group B | 4 (13.3%) | 6 (20.0%) | 10 (16.7%) | ||
| Group AB | 5 (16.7%) | 7 (23.3%) | 12 (20.0%) | ||
| Group O | 14 (46.7%) | 12 (40.0%) | 26 (43.3%) | ||
| Group A | 8 (26.7%) | 7 (23.3%) | 15 (25.0%) | Chi2 = .39#, | |
| Group B | 5 (16.7%) | 6 (20.0%) | 11 (18.3%) | ||
| Group AB | 2 (6.7%) | 3 (10.0%) | 5 (8.3%) | ||
| Group O | 15 (50.0%) | 14 (46.7%) | 29 (48.3%) | ||
All values, except P value*, and Chi2# are expressed in number (%) or mean ± SD, S: significant, NS: non-significant.
Outcome variables of the two groups.
| Outcome variable | Group A (phototherapy with reflectors) (n = 30) | Group B (phototherapy without reflectors) (n = 30) | |
|---|---|---|---|
| At 12 h | 14.95 (2.98) | 16.88 (2.51) | .009(S) |
| At 24 h | 11.65 (2.92) | 14.25 (2.14) | .001(S) |
| On second day | 8.73 (2.06) | 11.36 (2.01) | .001(S) |
| On discharge | 7.26 (0.58) | 8.26 (1.46) | .001(S) |
| 3.50 (0.51) | 4.43 (0.50) | .001(S) | |
S: significant.
Statistically significant decrease of levels in group A in comparison to their basal values.
Statistically significant decrease of levels in group B in comparison to their basal values.
Figure 3Total bilirubin concentration in the two groups at different time intervals.
Figure 4Comparison between group A and group B in regard to the duration of hospitalization.
Correlation between duration of hospital stay and decrease in bilirubin (difference between the first and last days).
| Total serum bilirubin change in group A | Total serum bilirubin change in group B | Bilirubin change in all patients | ||
|---|---|---|---|---|
| Hospital stays | r | −0.585 | −0.274 | −0.038 |
| p | 0.001(S) | 0.143(NS) | 0.772(NS) | |
| n. | 30 | 30 | 60 | |
Incidence of complications in studied groups.
| Group A | Group B | Total | ||
|---|---|---|---|---|
| Complications | Fever | 2 (6.7%) | 4 (13.3%) | 6 s (10.0%) |
| No complications | 28 (93.3%) | 26 (86.7%) | 54 (90.0%) | |
| Statistics | X2 = 0.74, p = 0.38 | |||